MIRA INFORM REPORT

 

 

Report Date :

20.11.2013

 

IDENTIFICATION DETAILS

 

Name :

GE HEALTHCARE JAPAN CORPORATION

 

 

Registered Office :

4-7-127 Asahigaoka Hino City Tokyo-Metrop 191-0065

 

 

Country :

Japan

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

October 1983

 

 

Legal Form :

Limited Company (Kabushiki Kaisha)

 

 

Line of Business :

Manufacturer of diagnostic imaging medical apparatus

 

 

No. of Employees :

2,114

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limits :

YEN 3,959.9 Million

Status :

Satisfactory

Payment Behaviour :

No complaints

Litigation :

Clear

 


 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

JAPAN - ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession three times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. The economy has largely recovered in the two years since the disaster, but reconstruction in the Tohoku region has been uneven. Newly-elected Prime Minister Shinzo ABE has declared the economy his government's top priority; he has pledged to reconsider his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus and regulatory reform and has said he will press the Bank of Japan to loosen monetary policy. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2012 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The new government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which exceeds 200% of GDP. Persistent deflation, reliance on exports to drive growth, and an aging and shrinking population are other major long-term challenges for the econom

Source : CIA


COMPANY NAME AND ADDRESS

 

GE HEALTHCARE JAPAN CORPORATION

 

 

REGD NAME:    GE Healthcare Japan KK

MAIN OFFICE:  4-7-127 Asahigaoka Hino City Tokyo-Metrop 191-0065 JAPAN

Tel: 042-585-5111     Fax: 042-585-5360

 

 

       URL:                      http://www.gehealthcare.co.jp/

E-Mail address: (thru the URL)

 

 

ACTIVITIES

 

Mfg of diagnostic imaging medical apparatus

 

 

BRANCHES   

 

Sapporo, Sendai, Saitama, Kobe, other (Tot 53)

 

 

FACTORIES  

 

At the caption address

 

 

OFFICER(S)  

 

JUN KAWAKAMI, PRES            Akihiko Kumagai, ch

Misa Yamashita, dir                   Atsuko Watanabe, dir

 

Yen Amount:     In million Yen, unless otherwise stated

 

 

SUMMARY    

 

FINANCES                    FAIR                             A/SALES          Yen 141,122 M

PAYMENTS                  NO COMPLAINTS          CAPITAL           Yen 6,016 M

TREND             UP                                WORTH            Yen 31,005 M

STARTED                     1983                             EMPLOYES      2,114

 

COMMENT    

 

MFR SPECIALIZING IN MEDICAL APPARATUS

FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS

 

MAX CREDIT LIMIT: YEN 3,959.9 MILLION, NORMAL TERMS

 

 

HIGHLIGHTS

 

The subject company was established as a JV between GE (General Electric) and Yokogawa Electric Corp, as Yokogawa Medical Systems Inc to operate as a Japanese branch of GE Medical Systems.  It was renamed as GE Yokogawa Medical Systems Ltd in 1994.  In 2009, the firm merged with GE Healthcare Bioscience Corporation, and renamed as captioned.  The subject specializes in mfg diagnostic medical imaging systems, related equipment, apparatus, parts & components.  Goods are also imported.  Clients are hospitals (public & private), universities, medical institutes, other.  Also marketed through 53 agent dealers nationwide.

 

 

FINANCIAL INFORMATION

 

The sales volume for Dec/2012 fiscal term amounted to Yen 141,122 million, a 2% up from Yen 138,044 million in the previous term.  The recurring profit was posted at Yen 17,685 million and the net profit at Yen 9,804 million, respectively, compared with Yen 18,326 million recurring profit and Yen 12,104 million net profit, respectively, a year ago.

 

For the current term ending Dec 2013 the recurring profit is projected at Yen 18,000 million and the net profit at Yen 10,000 million, respectively, on a 5% rise in turnover, to Yen 148,000 million.  The business is seen expanding steadily.

 

The financial situation is considered FAIR and good for ORDINARY business engagements.  Max credit limit is estimated at Yen 3,959.9 million, on normal terms. 

 

 

REGISTRATION

 

Date Registered:         Oct 1983

Legal Status:      Limited Company (Kabushiki Kaisha)

Authorized:         12,032,960,000 shares

Issued:                12,032,960,000 shares

Sum:                   Yen 6,016.48 million

Major shareholders (%): GE International Japan Investment BV (60), Yokogawa Electric Corp* (25), General  Electric Co (15)

No. of shareholders: 3

 

*..Mfr of industrial instruments, Tokyo, founded 1920, listed Tokyo S/E, capital Yen 43,401 million, sales Yen 347,899 million, operating profit Yen 18,409 million, recurring profit Yen 18,002 million, net profit Yen 14,688 million, total assets Yen 381,465 million, net worth Yen 172,470 million, employees 19,821, pres Takashi Nishijima

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

 

Activities: Manufactures diagnostic medical imaging systems (computerized), their equipment, parts, components and related apparatus (--100%).

 

Clients: Public & Private Hospitals, Universities, Medical Institutes, Medical Equipment dealers, agent dealership

No. of accounts: 1,000

Domestic areas of activities: Nationwide

Suppliers: [Mfrs] Yokogawa Electric, General Electric, Yokogawa Toa Kogyo, GE Healthcare, other.

 

Payment record: No complaints

 

Location: Business area in Hino City, Tokyo-Metrop.  Office premises at the caption address are owned and maintained satisfactorily.

 

Bank References:        Mizuho Bank (Mitaka)

                                    Relations: Satisfactory

 

 

FINANCES

 

(In Million Yen)

 

       Terms Ending:

31/12/2013

31/12/2012

31/12/2011

31/12/2010

Annual Sales

 

148,000

141,122

138,044

136,316

Recur. Profit

 

18,000

17,685

18,326

16,837

Net Profit

 

10,000

9,804

12,104

6,371

Total Assets

 

 

67,596

75,250

73,924

Current Assets

 

 

50,827

57,590

54,087

Current Liabs

 

 

27,046

25,399

24,952

Net Worth

 

 

31,005

41,216

40,144

Capital, Paid-Up

 

 

6,016

6,016

6,016

Div.P.Share(¥)

 

 

0.00

0.00

0.00

<Analytical Data>

(%)

(%)

(%)

(%)

    S.Growth Rate

4.87

2.23

1.27

14.51

    Current Ratio

 

..

187.93

226.74

216.76

    N.Worth Ratio

..

45.87

54.77

54.30

    R.Profit/Sales

 

12.16

12.53

13.28

12.35

    N.Profit/Sales

6.76

6.95

8.77

4.67

    Return On Equity

..

31.62

29.37

15.87

 

Notes: Forecast (or estimated) figures for the 31/12/2013 fiscal term.

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.23

UK Pound

1

Rs.100.18

Euro

1

Rs.84.06

 

 

INFORMATION DETAILS

 

Report Prepared by :

NIS

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.